Bangor Savings Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bangor Savings Bank’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10	Closed	–	–	547
2022 Q4	$0	Buy	+10	New	+$317	﹤0.01%	528

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bangor Savings Bank's ARKG Position: Q1 2023 in Review

Bangor Savings Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 10 shares.

Bangor Savings Bank first reported a position in ARKG in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Bangor Savings Bank reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Bangor Savings Bank sold 10 ARK Genomic Revolution ETF shares in Q1 2023.
Bangor Savings Bank first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 1 quarter.
Bangor Savings Bank's ARK Genomic Revolution ETF position peaked at $0 in Q4 2022.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Bangor Savings Bank's 13F filing for Q1 2023, filed 6 Apr 2023.